Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.1K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

1.0K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.0K
Depression: Overview01:18

Depression: Overview

1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
Long-term Depression01:05

Long-term Depression

33.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.6K
Long-term Depression01:03

Long-term Depression

3.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.5K
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

738
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
738

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advancing the development of diagnostic criteria for clinical depression by scientific strategies.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists·2026
Same author

Faecal Transplantation for Bipolar Disorder.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Same author

A further piece of my mind.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists·2026
Same author

MAOI Antidepressants: A History Being Rewritten.

The Journal of clinical psychiatry·2025
Same author

Burnout: At times a physical state.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists·2025
Same author

Current issues in relation to burnout's definition, measurement, prevalence and management: A narrative review.

Psychiatry research·2025
Same journal

Intergenerational conflicts in the families of immigrant Chinese mental health service users in New Zealand: A qualitative study.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists·2026
Same journal

Viewpoint: Time to enable accelerated psychiatry training.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists·2026
Same journal

Adult-onset attention-deficit/hyperactivity disorder as neuroadaptation: rethinking attention in the modern environment.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists·2026
Same journal

The impact of the COVID-19 pandemic on admissions to an adolescent inpatient psychiatric unit.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists·2026
Same journal

Understanding the equally well framework in older adult community mental health services: A qualitative study of allied health clinician perspectives.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists·2026
Same journal

Prevalence of mental illness in Northern Territory prisoners.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists·2026
See all related articles

Related Experiment Video

Updated: Mar 18, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

686

Managing melancholic depression: a personal perspective.

Gordon Parker1

  • 1Scientia Professor of Psychiatry, University of New South Wales, Randwick, NSW, and; Professorial Fellow, Black Dog Institute, Randwick, NSW, Australia.

Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists
|July 14, 2016
PubMed
Summary
This summary is machine-generated.

Managing melancholia requires prioritizing medication, as not all antidepressants are equally effective. Effective treatment often involves broad-spectrum drugs and augmentation strategies due to low response rates with single agents.

Keywords:
antidepressant drugsaugmentationmelancholia

More Related Videos

Evaluating the Anti-depression Effect of Xiaoyaosan on Chronically-stressed Mice
06:08

Evaluating the Anti-depression Effect of Xiaoyaosan on Chronically-stressed Mice

Published on: January 7, 2019

9.8K
Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

8.3K

Related Experiment Videos

Last Updated: Mar 18, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

686
Evaluating the Anti-depression Effect of Xiaoyaosan on Chronically-stressed Mice
06:08

Evaluating the Anti-depression Effect of Xiaoyaosan on Chronically-stressed Mice

Published on: January 7, 2019

9.8K
Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

8.3K

Area of Science:

  • Psychiatry
  • Clinical Pharmacology

Background:

  • Melancholia presents unique management challenges.
  • Limited evidence exists for optimal treatment strategies.

Purpose of the Study:

  • To provide a clinical perspective on managing melancholia.
  • To interpret existing evidence and clinical observations.

Main Methods:

  • Review of limited evidence base.
  • Clinical observations and experience.

Main Results:

  • Medication is a primary treatment consideration for melancholia.
  • Antidepressant potency varies significantly in melancholia.
  • Monotherapy with single antidepressants shows low response rates.

Conclusions:

  • Prioritize medication for melancholia management.
  • Utilize broad-spectrum antidepressant drugs.
  • Employ augmentation strategies for enhanced efficacy.